Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1998
03/18/1998EP0828518A1 Gene transfer for treating a connective tissue of a mammalian host
03/18/1998EP0828515A1 Antibacterial-wound healing compositions and methods for preparing and using same
03/18/1998EP0828512A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
03/18/1998EP0828509A1 Composition to improve digestibility and utilisation of nutrients
03/18/1998EP0828508A2 Compositions of interleukin and pyrimidine nucleosides
03/18/1998EP0828507A1 Method for treatment of pain
03/18/1998EP0828506A2 Endoparasiticidal agents
03/18/1998EP0828505A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
03/18/1998EP0828504A2 Method for treating huntington's disease using glial cell line-derived neurotrophic factor (gdnf) protein product
03/18/1998EP0828503A1 Treatment for inhibiting the progression of autoimmune disease
03/18/1998EP0828486A1 Use of pyrrolidine derivatives for treating alcoholism
03/18/1998EP0828481A1 Oral dosage composition for intestinal delivery and method of use of the same
03/18/1998EP0828478A1 Osmotic device with delayed activation of drug delivery and complete drug release
03/18/1998EP0739214B1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
03/18/1998EP0563329B1 Angiogenic peptides
03/18/1998EP0535148B1 Stimulation of bone marrow stromal and progenitor cells
03/18/1998EP0532546B1 A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
03/18/1998EP0525119B1 Antibody conjugates for treatment of neoplastic disease
03/18/1998EP0460232B1 Tumor cell growth inhibitor
03/18/1998CN1176662A Identification of genes
03/18/1998CN1176659A A method for making heteromultimeric polypeptides
03/18/1998CN1176658A Vaccine and antitoxin for treatment and prevention of C. difficile disease
03/18/1998CN1176648A A method of identifying CFTR-binding compounds useful for activating chloride conductance in animal cells
03/18/1998CN1176647A Isolated, truncated nucleic acid molecules which code for GAGE tumor rejection antigen
03/18/1998CN1176646A CCK or gastrin modulating 5 -heterocyclic-1, 5-benzodiazepines
03/18/1998CN1176645A Compounds with growth hormone releasing properties
03/18/1998CN1176603A Vascular endothelial growth factor-B
03/18/1998CN1176391A Monoclonal antibodies against human interleukin-4 and hybridowas producing the same
03/17/1998US5729042 Raised fuse structure for laser repair
03/17/1998US5728868 Prodrugs of protein tyrosine kinase inhibitors
03/17/1998US5728821 Mutant BR96 antibodies reactive with human carcinomas
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728815 Bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
03/17/1998US5728814 Monoclonal antibodies, hybridoma cell line
03/17/1998US5728813 Antibodies directed against elk ligand
03/17/1998US5728812 Anti-idiotypic antibody composition for inhibiting acute complement-mediated cytotoxicity
03/17/1998US5728808 Human Prostaglandin receptor IP
03/17/1998US5728807 Genetic disorders
03/17/1998US5728805 Purified protein having antitumor activity
03/17/1998US5728803 Pantropic neurotrophic factors
03/17/1998US5728802 Polypeptides for adhesion of leukocytes
03/17/1998US5728711 Antiulcer agents
03/17/1998US5728707 Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide
03/17/1998US5728687 Antitumour compositions containing taxane derivatives
03/17/1998US5728680 Methods for normalizing numbers of lymphocytes
03/17/1998US5728679 BMP-15 compositions
03/17/1998US5728678 Method and composition for providing nutrition to a renal failure patient
03/17/1998US5728677 Administering a specified polypeptide to a mammal
03/17/1998US5728676 Use of insulin-like growth factors I and II for inhibition of inflammatory response
03/17/1998US5728674 Polypeptides as anticoagulants
03/17/1998US5728579 Therapeutic targets for treatment of breast cancer
03/17/1998US5728567 Tissue plasminogen activator having zymogenic or fibrin specific properties
03/17/1998US5728566 Tissue plasminogen activator derivatives
03/17/1998US5728565 Methods of preparing tissue plasminogen activator derivatives
03/17/1998US5728564 U-PA mutants resistant to inhibition by their cognate inhibitors
03/17/1998US5728560 Treating hiv-infected patients using adenosine deaminase
03/17/1998US5728549 Gene expression vectors with controlling sequences of dna
03/17/1998US5728546 Polypeptides and polynucleotides
03/17/1998US5728540 Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification
03/17/1998US5728536 Jak kinases and regulation of Cytokine signal transduction
03/17/1998US5728533 Human β2 integrin αsubunit
03/17/1998US5728523 Polymerase delta mutations in colorectal tumors with replication errors
03/17/1998US5728521 Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
03/17/1998US5728520 Immunoreactive polypeptide compositions
03/17/1998US5728518 Soluble complex of a poly- or oligonucleotide and a carrier
03/17/1998US5728396 Sustained delivery of leuprolide using an implantable system
03/17/1998US5728388 Contacting sample comprising tumor-sensitized cells with superantigens to produce stimulated cells, infusing into tumor bearing host
03/17/1998US5728383 Treatment of tumors of the central nervous system with immunotoxins
03/17/1998US5728381 Diagnosis and treatment of hunter syndrome
03/17/1998US5728379 Tumor- or cell-specific herpes simplex virus replication
03/17/1998US5728378 Antitumor and antivirus agents
03/17/1998US5728377 Ip-10 is myelosuppressive protein secreted by human keratinocytes, monocytes, endothelial cells; anticancer agent
03/17/1998US5728369 Radioactive phosphorus labeling of proteins for targeted radiotherapy
03/17/1998CA2185600A1 Water-soluble concentrates containing cyclosporins
03/17/1998CA1339760C Antihypertensive hyperimmine milk, prodiction, composition, and use
03/17/1998CA1339759C Stable bioactive somatotropins
03/17/1998CA1339758C Human reg protein
03/17/1998CA1339757C Production of purified biologically active, bacterially produced recombinant human csf-1
03/17/1998CA1339756C Peptide derivatives and antidementia agents
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/16/1998CA2196727A1 Cyclin dependent kinase inhibitor p27kip1 and method for decreasing adhesion-dependent resistance of tumor cells to anticancer agents
03/12/1998WO1998010090A1 Gata-6 transcription factor: compositions and methods
03/12/1998WO1998010087A1 Chimpanzee adenovirus vectors
03/12/1998WO1998010085A2 Gene therapy for congestive heart failure
03/12/1998WO1998010083A1 Herpesvirus saimiri as viral vector
03/12/1998WO1998010076A2 Phospholipase d and dna sequences
03/12/1998WO1998010071A1 Angiogenic factor and use thereof in treating cardiovascular disease
03/12/1998WO1998010069A2 E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF
03/12/1998WO1998010068A2 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998WO1998010067A1 Human homolog of the latheo gene
03/12/1998WO1998010066A1 Modulators of brca1 activity
03/12/1998WO1998010065A1 Breast carcinoma-associated gene
03/12/1998WO1998010056A1 Treatment of antigen presenting cells to modulate antigen presenting cell function
03/12/1998WO1998009993A1 Novel protease inhibitors derived from guamerin
03/12/1998WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS
03/12/1998WO1998009991A2 Enteric neural peptide
03/12/1998WO1998009989A1 The use of muramylpeptides in the treatment of myelosuppressed or otherwise immunocompromised states
03/12/1998WO1998009986A1 S-blocked glutathiones
03/12/1998WO1998009985A2 Anti-inflammatory peptides and uses thereof
03/12/1998WO1998009984A1 Central nervous system-derived immune privilege factor and uses thereof
1 ... 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 ... 3163